Suchbegriffe: DERIVED NEUTROPHIL-LYMPHOCYTE RATIO, . Treffer: 3
Dalpiaz, O; Luef, T; Seles, M; Stotz, M; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M
Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
Br J Cancer. 2017; 116(1):85-90
Doi: 10.1038/bjc.2016.393
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Belaj, K; Pichler, M; Hackl, G; Rief, P; Eller, P; Hafner, F; Brodmann, M; Gary, T
Association of the Derived Neutrophil-Lymphocyte Ratio With Critical Limb Ischemia.
Angiology. 2016; 67(4):350-354
Doi: 10.1177/0003319715590701
Web of Science
PubMed
FullText
FullText_MUG
Dalpiaz, O; Pichler, M; Mannweiler, S; Martín Hernández, JM; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC
Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
Br J Cancer. 2014; 110(10):2531-2536
Doi: 10.1038/bjc.2014.180
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG